PRIMARY LIGHT-CHAIN AMYLOIDOSIS

Clinical trials for PRIMARY LIGHT-CHAIN AMYLOIDOSIS explained in plain language.

Never miss a new study

Get alerted when new PRIMARY LIGHT-CHAIN AMYLOIDOSIS trials appear

Sign up with your email to follow new studies for PRIMARY LIGHT-CHAIN AMYLOIDOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New drug trial targets Tough-to-Treat amyloidosis

Disease control Recruiting now

This study is testing an experimental drug called CM336 in adults whose primary light-chain amyloidosis has returned or hasn't responded to previous treatments. The trial aims to see if CM336 can help control the disease by measuring blood response rates and checking safety. Abou…

Matched conditions: PRIMARY LIGHT-CHAIN AMYLOIDOSIS

Phase: PHASE2 • Sponsor: Keymed Biosciences Co.Ltd • Aim: Disease control

Last updated Mar 30, 2026 14:32 UTC

PRIMARY LIGHT-CHAIN AMYLOIDOSIS

Get alerted when new PRIMARY LIGHT-CHAIN AMYLOIDOSIS trials appear

New drug trial targets Tough-to-Treat amyloidosis